 | • レポートコード：QYR2104Z1132 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、心肺ストレス検査システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心肺運動検査（CPET）システム、ストレスECG、パルスオキシメータ、ストレス血圧計、単一光子放射型コンピュータ断層撮影（SPECT））、用途別市場規模（病院、専門クリニック/循環器クリニック、外来手術センター、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・心肺ストレス検査システムの市場動向 ・企業の競争状況、市場シェア ・心肺ストレス検査システムの種類別市場規模（心肺運動検査（CPET）システム、ストレスECG、パルスオキシメータ、ストレス血圧計、単一光子放射型コンピュータ断層撮影（SPECT）） ・心肺ストレス検査システムの用途別市場規模（病院、専門クリニック/循環器クリニック、外来手術センター、診断センター） ・心肺ストレス検査システムの北米市場規模2016-2027（アメリカ、カナダ） ・心肺ストレス検査システムのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・心肺ストレス検査システムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心肺ストレス検査システムの中南米市場規模2016-2027（メキシコ、ブラジル） ・心肺ストレス検査システムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BD、GE Healthcare、Philips Healthcare、Spacelabs Healthcare、Cardinal Health、Fukuda Denshi、MGC Diagnostic、Mortara Instrument、Nihon Kohden、Schiller、SunTech Medical、Hill-Rom） ・結論 |
Global cardiopulmonary stress testing systems market is mainly driven by the rising demand for high value low volume products, and increasing innovations in the new product launches. The market is witnessing growing trend of introduction of wireless devices, and increasing awareness for early diagnosis of cardiovascular diseases is anticipated to steer the global market growth. Significant technological advancement in cardiopulmonary stress testing systems are likely to drive the market growth, and value added service assistance of these devices serves as major opportunity for the players operating in the cardiopulmonary stress testing systems space.
The global cardiopulmonary stress testing systems market is driven by several crucial factors. Diagnosis of proper functioning of the heart remains the first line of treatment that helps physicians to assess the health status of patients who are at risk of cardiovascular diseases. A stress test helps physicians to evaluate the heart functioning based on several parameters such as blood pressure, heart rhythm, breathing, etc. and is performed typically on treadmill or cycle. For instance, stress echocardiography involves capturing ultrasound images of heart when the heart reaches peak level, which gives insights about the supply of blood and oxygen from the heart while performing an exercise. Alternately, an imaging test is conducted if the patient is unable to walk on the treadmill or cycle or if the exercise stress test does not give satisfactory results to diagnose the cause of heart problem.
Market Analysis and Insights: Global Cardiopulmonary Stress Testing Systems Market
The global Cardiopulmonary Stress Testing Systems market size is projected to reach US$ 6394.9 million by 2026, from US$ 4056.4 million in 2019, at a CAGR of 6.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cardiopulmonary Stress Testing Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cardiopulmonary Stress Testing Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cardiopulmonary Stress Testing Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cardiopulmonary Stress Testing Systems market.
Global Cardiopulmonary Stress Testing Systems Scope and Market Size
Cardiopulmonary Stress Testing Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiopulmonary Stress Testing Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cardiopulmonary Exercise Testing (CPET) Systems
Stress ECG
Pulse Oximeters
Stress Blood Pressure Monitors
Single-Photon Emission Computed Tomography (SPECT)
Segment by Application
Hospitals
Specialty Clinics/Cardiology Clinics
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BD
GE Healthcare
Philips Healthcare
Spacelabs Healthcare
Cardinal Health
Fukuda Denshi
MGC Diagnostic
Mortara Instrument
Nihon Kohden
Spacelabs Healthcare
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiopulmonary Stress Testing Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cardiopulmonary Exercise Testing (CPET) Systems
1.2.3 Stress ECG
1.2.4 Pulse Oximeters
1.2.5 Stress Blood Pressure Monitors
1.2.6 Single-Photon Emission Computed Tomography (SPECT)
1.3 Market by Application
1.3.1 Global Cardiopulmonary Stress Testing Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics/Cardiology Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cardiopulmonary Stress Testing Systems Market Perspective (2016-2027)
2.2 Cardiopulmonary Stress Testing Systems Growth Trends by Regions
2.2.1 Cardiopulmonary Stress Testing Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cardiopulmonary Stress Testing Systems Historic Market Share by Regions (2016-2021)
2.2.3 Cardiopulmonary Stress Testing Systems Forecasted Market Size by Regions (2022-2027)
2.3 Cardiopulmonary Stress Testing Systems Industry Dynamic
2.3.1 Cardiopulmonary Stress Testing Systems Market Trends
2.3.2 Cardiopulmonary Stress Testing Systems Market Drivers
2.3.3 Cardiopulmonary Stress Testing Systems Market Challenges
2.3.4 Cardiopulmonary Stress Testing Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiopulmonary Stress Testing Systems Players by Revenue
3.1.1 Global Top Cardiopulmonary Stress Testing Systems Players by Revenue (2016-2021)
3.1.2 Global Cardiopulmonary Stress Testing Systems Revenue Market Share by Players (2016-2021)
3.2 Global Cardiopulmonary Stress Testing Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cardiopulmonary Stress Testing Systems Revenue
3.4 Global Cardiopulmonary Stress Testing Systems Market Concentration Ratio
3.4.1 Global Cardiopulmonary Stress Testing Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiopulmonary Stress Testing Systems Revenue in 2020
3.5 Cardiopulmonary Stress Testing Systems Key Players Head office and Area Served
3.6 Key Players Cardiopulmonary Stress Testing Systems Product Solution and Service
3.7 Date of Enter into Cardiopulmonary Stress Testing Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiopulmonary Stress Testing Systems Breakdown Data by Type
4.1 Global Cardiopulmonary Stress Testing Systems Historic Market Size by Type (2016-2021)
4.2 Global Cardiopulmonary Stress Testing Systems Forecasted Market Size by Type (2022-2027)
5 Cardiopulmonary Stress Testing Systems Breakdown Data by Application
5.1 Global Cardiopulmonary Stress Testing Systems Historic Market Size by Application (2016-2021)
5.2 Global Cardiopulmonary Stress Testing Systems Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cardiopulmonary Stress Testing Systems Market Size (2016-2027)
6.2 North America Cardiopulmonary Stress Testing Systems Market Size by Type
6.2.1 North America Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021)
6.2.2 North America Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027)
6.2.3 North America Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2027)
6.3 North America Cardiopulmonary Stress Testing Systems Market Size by Application
6.3.1 North America Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021)
6.3.2 North America Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027)
6.3.3 North America Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2027)
6.4 North America Cardiopulmonary Stress Testing Systems Market Size by Country
6.4.1 North America Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021)
6.4.2 North America Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cardiopulmonary Stress Testing Systems Market Size (2016-2027)
7.2 Europe Cardiopulmonary Stress Testing Systems Market Size by Type
7.2.1 Europe Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021)
7.2.2 Europe Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027)
7.2.3 Europe Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2027)
7.3 Europe Cardiopulmonary Stress Testing Systems Market Size by Application
7.3.1 Europe Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021)
7.3.2 Europe Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027)
7.3.3 Europe Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2027)
7.4 Europe Cardiopulmonary Stress Testing Systems Market Size by Country
7.4.1 Europe Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021)
7.4.2 Europe Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size (2016-2027)
8.2 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Type
8.2.1 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Application
8.3.1 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Region
8.4.1 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cardiopulmonary Stress Testing Systems Market Size (2016-2027)
9.2 Latin America Cardiopulmonary Stress Testing Systems Market Size by Type
9.2.1 Latin America Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021)
9.2.2 Latin America Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027)
9.2.3 Latin America Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2027)
9.3 Latin America Cardiopulmonary Stress Testing Systems Market Size by Application
9.3.1 Latin America Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021)
9.3.2 Latin America Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027)
9.3.3 Latin America Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2027)
9.4 Latin America Cardiopulmonary Stress Testing Systems Market Size by Country
9.4.1 Latin America Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021)
9.4.2 Latin America Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size (2016-2027)
10.2 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Type
10.2.1 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Application
10.3.1 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Country
10.4.1 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Cardiopulmonary Stress Testing Systems Introduction
11.1.4 BD Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.1.5 BD Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Cardiopulmonary Stress Testing Systems Introduction
11.2.4 GE Healthcare Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Philips Healthcare
11.3.1 Philips Healthcare Company Details
11.3.2 Philips Healthcare Business Overview
11.3.3 Philips Healthcare Cardiopulmonary Stress Testing Systems Introduction
11.3.4 Philips Healthcare Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.3.5 Philips Healthcare Recent Development
11.4 Spacelabs Healthcare
11.4.1 Spacelabs Healthcare Company Details
11.4.2 Spacelabs Healthcare Business Overview
11.4.3 Spacelabs Healthcare Cardiopulmonary Stress Testing Systems Introduction
11.4.4 Spacelabs Healthcare Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.4.5 Spacelabs Healthcare Recent Development
11.5 Cardinal Health
11.5.1 Cardinal Health Company Details
11.5.2 Cardinal Health Business Overview
11.5.3 Cardinal Health Cardiopulmonary Stress Testing Systems Introduction
11.5.4 Cardinal Health Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.5.5 Cardinal Health Recent Development
11.6 Fukuda Denshi
11.6.1 Fukuda Denshi Company Details
11.6.2 Fukuda Denshi Business Overview
11.6.3 Fukuda Denshi Cardiopulmonary Stress Testing Systems Introduction
11.6.4 Fukuda Denshi Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.6.5 Fukuda Denshi Recent Development
11.7 MGC Diagnostic
11.7.1 MGC Diagnostic Company Details
11.7.2 MGC Diagnostic Business Overview
11.7.3 MGC Diagnostic Cardiopulmonary Stress Testing Systems Introduction
11.7.4 MGC Diagnostic Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.7.5 MGC Diagnostic Recent Development
11.8 Mortara Instrument
11.8.1 Mortara Instrument Company Details
11.8.2 Mortara Instrument Business Overview
11.8.3 Mortara Instrument Cardiopulmonary Stress Testing Systems Introduction
11.8.4 Mortara Instrument Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.8.5 Mortara Instrument Recent Development
11.9 Nihon Kohden
11.9.1 Nihon Kohden Company Details
11.9.2 Nihon Kohden Business Overview
11.9.3 Nihon Kohden Cardiopulmonary Stress Testing Systems Introduction
11.9.4 Nihon Kohden Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.9.5 Nihon Kohden Recent Development
11.10 Schiller
11.10.1 Schiller Company Details
11.10.2 Schiller Business Overview
11.10.3 Schiller Cardiopulmonary Stress Testing Systems Introduction
11.10.4 Schiller Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.10.5 Schiller Recent Development
11.11 SunTech Medical
11.11.1 SunTech Medical Company Details
11.11.2 SunTech Medical Business Overview
11.11.3 SunTech Medical Cardiopulmonary Stress Testing Systems Introduction
11.11.4 SunTech Medical Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.11.5 SunTech Medical Recent Development
11.12 Hill-Rom
11.12.1 Hill-Rom Company Details
11.12.2 Hill-Rom Business Overview
11.12.3 Hill-Rom Cardiopulmonary Stress Testing Systems Introduction
11.12.4 Hill-Rom Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021)
11.12.5 Hill-Rom Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cardiopulmonary Stress Testing Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cardiopulmonary Exercise Testing (CPET) Systems
Table 3. Key Players of Stress ECG
Table 4. Key Players of Pulse Oximeters
Table 5. Key Players of Stress Blood Pressure Monitors
Table 6. Key Players of Single-Photon Emission Computed Tomography (SPECT)
Table 7. Global Cardiopulmonary Stress Testing Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cardiopulmonary Stress Testing Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cardiopulmonary Stress Testing Systems Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cardiopulmonary Stress Testing Systems Market Share by Regions (2016-2021)
Table 11. Global Cardiopulmonary Stress Testing Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cardiopulmonary Stress Testing Systems Market Share by Regions (2022-2027)
Table 13. Cardiopulmonary Stress Testing Systems Market Trends
Table 14. Cardiopulmonary Stress Testing Systems Market Drivers
Table 15. Cardiopulmonary Stress Testing Systems Market Challenges
Table 16. Cardiopulmonary Stress Testing Systems Market Restraints
Table 17. Global Cardiopulmonary Stress Testing Systems Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cardiopulmonary Stress Testing Systems Market Share by Players (2016-2021)
Table 19. Global Top Cardiopulmonary Stress Testing Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiopulmonary Stress Testing Systems as of 2020)
Table 20. Ranking of Global Top Cardiopulmonary Stress Testing Systems Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cardiopulmonary Stress Testing Systems Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cardiopulmonary Stress Testing Systems Product Solution and Service
Table 24. Date of Enter into Cardiopulmonary Stress Testing Systems Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cardiopulmonary Stress Testing Systems Revenue Market Share by Type (2016-2021)
Table 28. Global Cardiopulmonary Stress Testing Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cardiopulmonary Stress Testing Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cardiopulmonary Stress Testing Systems Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cardiopulmonary Stress Testing Systems Revenue Market Share by Application (2016-2021)
Table 32. Global Cardiopulmonary Stress Testing Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cardiopulmonary Stress Testing Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size by Country (2022-2027) & (US$ Million)
Table 64. BD Company Details
Table 65. BD Business Overview
Table 66. BD Cardiopulmonary Stress Testing Systems Product
Table 67. BD Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 68. BD Recent Development
Table 69. GE Healthcare Company Details
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare Cardiopulmonary Stress Testing Systems Product
Table 72. GE Healthcare Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 73. GE Healthcare Recent Development
Table 74. Philips Healthcare Company Details
Table 75. Philips Healthcare Business Overview
Table 76. Philips Healthcare Cardiopulmonary Stress Testing Systems Product
Table 77. Philips Healthcare Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 78. Philips Healthcare Recent Development
Table 79. Spacelabs Healthcare Company Details
Table 80. Spacelabs Healthcare Business Overview
Table 81. Spacelabs Healthcare Cardiopulmonary Stress Testing Systems Product
Table 82. Spacelabs Healthcare Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 83. Spacelabs Healthcare Recent Development
Table 84. Cardinal Health Company Details
Table 85. Cardinal Health Business Overview
Table 86. Cardinal Health Cardiopulmonary Stress Testing Systems Product
Table 87. Cardinal Health Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 88. Cardinal Health Recent Development
Table 89. Fukuda Denshi Company Details
Table 90. Fukuda Denshi Business Overview
Table 91. Fukuda Denshi Cardiopulmonary Stress Testing Systems Product
Table 92. Fukuda Denshi Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 93. Fukuda Denshi Recent Development
Table 94. MGC Diagnostic Company Details
Table 95. MGC Diagnostic Business Overview
Table 96. MGC Diagnostic Cardiopulmonary Stress Testing Systems Product
Table 97. MGC Diagnostic Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 98. MGC Diagnostic Recent Development
Table 99. Mortara Instrument Company Details
Table 100. Mortara Instrument Business Overview
Table 101. Mortara Instrument Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 102. Mortara Instrument Recent Development
Table 103. Nihon Kohden Company Details
Table 104. Nihon Kohden Business Overview
Table 105. Nihon Kohden Cardiopulmonary Stress Testing Systems Product
Table 106. Nihon Kohden Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 107. Nihon Kohden Recent Development
Table 108. Schiller Company Details
Table 109. Schiller Business Overview
Table 110. Schiller Cardiopulmonary Stress Testing Systems Product
Table 111. Schiller Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 112. Schiller Recent Development
Table 113. SunTech Medical Company Details
Table 114. SunTech Medical Business Overview
Table 115. SunTech Medical Cardiopulmonary Stress Testing Systems Product
Table 116. SunTech Medical Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 117. SunTech Medical Recent Development
Table 118. Hill-Rom Company Details
Table 119. Hill-Rom Business Overview
Table 120. Hill-Rom Cardiopulmonary Stress Testing Systems Product
Table 121. Hill-Rom Revenue in Cardiopulmonary Stress Testing Systems Business (2016-2021) & (US$ Million)
Table 122. Hill-Rom Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiopulmonary Stress Testing Systems Market Share by Type: 2020 VS 2027
Figure 2. Cardiopulmonary Exercise Testing (CPET) Systems Features
Figure 3. Stress ECG Features
Figure 4. Pulse Oximeters Features
Figure 5. Stress Blood Pressure Monitors Features
Figure 6. Single-Photon Emission Computed Tomography (SPECT) Features
Figure 7. Global Cardiopulmonary Stress Testing Systems Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics/Cardiology Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Cardiopulmonary Stress Testing Systems Report Years Considered
Figure 13. Global Cardiopulmonary Stress Testing Systems Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Cardiopulmonary Stress Testing Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Cardiopulmonary Stress Testing Systems Market Share by Regions: 2020 VS 2027
Figure 16. Global Cardiopulmonary Stress Testing Systems Market Share by Regions (2022-2027)
Figure 17. Global Cardiopulmonary Stress Testing Systems Market Share by Players in 2020
Figure 18. Global Top Cardiopulmonary Stress Testing Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiopulmonary Stress Testing Systems as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Cardiopulmonary Stress Testing Systems Revenue in 2020
Figure 20. Global Cardiopulmonary Stress Testing Systems Revenue Market Share by Type (2016-2021)
Figure 21. Global Cardiopulmonary Stress Testing Systems Revenue Market Share by Type (2022-2027)
Figure 22. North America Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Cardiopulmonary Stress Testing Systems Market Share by Type (2016-2027)
Figure 24. North America Cardiopulmonary Stress Testing Systems Market Share by Application (2016-2027)
Figure 25. North America Cardiopulmonary Stress Testing Systems Market Share by Country (2016-2027)
Figure 26. United States Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cardiopulmonary Stress Testing Systems Market Share by Type (2016-2027)
Figure 30. Europe Cardiopulmonary Stress Testing Systems Market Share by Application (2016-2027)
Figure 31. Europe Cardiopulmonary Stress Testing Systems Market Share by Country (2016-2027)
Figure 32. Germany Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Cardiopulmonary Stress Testing Systems Market Share by Region (2016-2027)
Figure 42. China Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cardiopulmonary Stress Testing Systems Market Share by Type (2016-2027)
Figure 50. Latin America Cardiopulmonary Stress Testing Systems Market Share by Application (2016-2027)
Figure 51. Latin America Cardiopulmonary Stress Testing Systems Market Share by Country (2016-2027)
Figure 52. Mexico Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Share by Country (2016-2027)
Figure 58. Turkey Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Cardiopulmonary Stress Testing Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. BD Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 62. GE Healthcare Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 63. Philips Healthcare Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 64. Spacelabs Healthcare Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 65. Cardinal Health Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 66. Fukuda Denshi Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 67. MGC Diagnostic Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 68. Mortara Instrument Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 69. Nihon Kohden Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 70. Schiller Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 71. SunTech Medical Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 72. Hill-Rom Revenue Growth Rate in Cardiopulmonary Stress Testing Systems Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の単一光子放射型コンピュータ断層撮影（SPECT）システム市場規模・現状・予測（2021年-2027年） Single-photon emission computed tomography (CT) is a radioisotope CT scan and belongs to the category of nuclear medicine. The imaging principle is a combination of radionuclide development and CT three-dimensional imaging technology, which can show the distribution of radioisotopes in different lay…- 世界の単一光子放射断層撮影（SPECT）市場規模・現状・予測（2021年-2027年） Preclinical SPECT imaging uses gamma rays to image rodent models of disease and is often combined with CT scans and PET imaging to generate quantifiable data on therapeutic compound binding and brain function. Market Analysis and Insights: Global Preclinical Single Photon Emission Computed Tomograph…
- 世界の医薬品用酸化ストレスアッセイ市場規模・現状・予測（2021年-2027年） Oxidative stress refers to the imbalance between oxidation and antioxidation in the body, which tends to oxidize, leading to the inflammatory infiltration of neutrophils, the increase of protease secretion, and the production of a large number of oxidation intermediates. The increasing investments i…
- 世界の心的外傷後ストレス障害（PTSD）治療薬市場規模・現状・予測（2021年-2027年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…
- 世界の酸化ストレス検出市場規模・現状・予測（2021年-2027年） Oxidative stress is a state of imbalance caused in cells when a free radical or a reactive oxygen species takes an electron from a molecule and causes a chain reaction leading to cell and tissue damage. Within the pharmaceutical industry, biopharmaceutical and biotechnology sectors are the primary u…